Gilead makes exclusive deal with CVS for hepatitis C drugs
(Bloomberg) — Gilead Sciences Inc. agreed to make its hepatitis C medicines the exclusive treatments for CVS Health Corp. customers, intensifying a drug-industry rivalry to win patients for t…
